Perinatal risk factors of renal outcome in former extremely low birth weight neonates

Marieke Colleman1, Jan A Staessen2,3, Karel Allegaert1,4,5

  • 1Department of Development and Regeneration, University of Leuven, Louvain, Belgium.

PubMed

Insights

Former Extremely Low Birthweight (ELBW) children face higher risks of kidney dysfunction, linked to longer ventilation, male sex, and intraventricular hemorrhage. This highlights the need for targeted follow-up and interventions for high-risk infants.

Area of Science:

  • Neonatology
  • Pediatric Nephrology
  • Cardiovascular Health

Background:

  • Extremely Low Birthweight (ELBW) neonates are known to experience adverse renal and cardiovascular outcomes in later life.
  • Perinatal risk factors contributing to these long-term adverse outcomes remain incompletely understood.

Purpose of the Study:

  • To compare renal outcomes between former ELBW children and healthy controls.
  • To identify perinatal risk factors associated with poorer renal outcomes in ELBW children.
  • To investigate the relationship between kidney function and blood pressure in this cohort.

Main Methods:

  • A cohort of 93 former ELBW children and 87 healthy controls (mean age 11 years) was assessed.
  • Cystatin C-based estimated glomerular filtration rate (eGFR) and blood pressure were measured.
  • Perinatal risk factors were analyzed in relation to renal outcomes among ELBW children.

Main Results:

  • ELBW children exhibited significantly higher blood pressure (SBP percentile 75th vs. 47th) and lower mean eGFR (94 vs. 107 ml/min/1.73 m²) compared to controls.
  • Poorer eGFR (<90 ml/min/1.73 m²) in ELBW children was associated with longer ventilation duration (17 vs. 9 days), male sex (OR=3.33), and a trend towards more intraventricular hemorrhage (40% vs. 15.8%).
  • No correlation was found between elevated blood pressure and perinatal characteristics; microalbuminuria was absent in all participants.

Conclusions:

  • Poorer eGFR in former ELBW children is linked to specific perinatal factors including longer ventilation, male sex, and intra-ventricular hemorrhage, but not blood pressure.
  • Identifying at-risk profiles can guide the development of safer neonatal therapeutic regimens and more intensive follow-up strategies.
  • Earlier treatment initiation for ELBW children identified as high-risk may improve long-term renal health outcomes.

Related Concept Videos

Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
62
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.4K
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
71
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
128